The importance of progesterone level at day of human chorionic gonadotropin (hCG) administration on pregnancy rate in the short-term protocol

Evaluation of relationship between progesterone level at the day of human chorionic gonadotropin administration and pregnancy rate.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12613000082707

Enrollment

104

Registered

2013-01-22

Start date

2011-07-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In our Center of Reproductive Medicine and Biology "Clinic Center Hera", 80% of patients are subjected to cycles with short-controlled ovarian stimulation protocol. The aim of this prospective study was to evaluate, based on our experience, the impact of elevated serum levels of progesterone in the day of human corionic gonadotropin administration on pregnancy rate.

Interventions

The ovarian stimulation protocol used has foreseen the intramuscular administration from the first day of the menstrual cycle of Triptorelin 0.1 mg / ml rFSH and until the day of HCG.In all patients was performed by supplementation of the luteal phase progesterone intravaginal 600mg daily

Eligibility

Sex/Gender

All

Age

20 Years to 38 Years

Healthy volunteers

Yes

Inclusion criteria

Patients scheduled for IVF-ICSI cycles with an average age of 35 years with basal FSH values <9 mIU/ml and a BMI normal.

Exclusion criteria

patients with more of 38 years, with basal FSH values >9 mIU/ml and a BMI abnormal.

Outcome results